Paraskevi, T., S. Jolien, S. Wendy, S. Adria, D. Katarina Stoklund, C. Adriana Margarida Barbosa, P. Arun, H. Andreas, D. Philip Van, M. Thomas and B. Ludo Van Den, 2023. PP2A and GSK3 act as modifiers of FUS-ALS by modulating mitochondrial transport. bioRxiv: 2023.2008.2028.555106.
Tags: hiPSC-derived motor neurons, myoblasts, neuromuscular junction (NMJ), preprint, XC150

Costamagna, D., V. Bastianini, M. Corvelyn, R. Duelen, J. Deschrevel, N. De Beukelaer, H. De Houwer, M. Sampaolesi, G. Gayan-Ramirez, A. V. Campenhout and K. Desloovere, 2023. Botulinum Toxin Treatment of Adult Muscle Stem Cells from Children with Cerebral Palsy and hiPSC-Derived Neuromuscular Junctions. Cells 12 DOI: 10.3390/cells12162072.
Tags: hiPSC-derived, lower motor neurons, myoblasts, neuromuscular junction (NMJ), XC150

Stoklund Dittlau, K., Terrie, L., Baatsen, P., Kerstens, A., De Swert, L., Janky, R.s., Corthout, N., Masrori, P., Van Damme, P., Hyttel, P., Meyer, M., Thorrez, L., Freude, K., Van Den Bosch, L., 2023. FUS-ALS hiPSC-derived astrocytes impair human motor units through both gain-of-toxicity and loss-of-support mechanisms. Molecular Neurodegeneration 18, 5. * uses XonaChips® (XC150) with co-culture of hiPSC-derived motor neurons and astrocytes with human primary myoblasts.
Tags: astrocytes, co-culture, hiPSC-derived motor neurons, myoblasts, XC150

Limone, F., Guerra San Juan, I., Mitchell, J.M., Smith, J.L.M., Raghunathan, K., Meyer, D., Ghosh, S.D., Couto, A., Klim, J.R., Joseph, B.J., Gold, J., Mello, C.J., Nemesh, J., Smith, B.M., Verhage, M., McCarroll, S.A., Pietiläinen, O., Nehme, R., Eggan, K., 2023. Efficient generation of lower induced motor neurons by coupling Ngn2 expression with developmental cues. Cell Reports 42, 111896. * uses XonaChips® (XC450) with co-culture of human lower induced motor neurons (liMNs) and primary murine myoblasts.
Tags: co-culture, hiPSC-derived motor neurons, myoblasts, XC450

Costamagna, D., Casters, V., Beltrà, M., Sampaolesi, M., Van Campenhout, A., Ortibus, E., Desloovere, K., Duelen, R., 2022. Autologous iPSC-Derived Human Neuromuscular Junction to Model the Pathophysiology of Hereditary Spastic Paraplegia, Cells. * uses XonaChips® (XC150) with human iPSC-differentiated lower motor neurons and myoblasts to create in vitro NMJs.
Tags: hereditary spastic paraplegia, hiPSC-derived motor neurons, lower motor neurons, myoblasts, neuromuscular junction (NMJ), XC150

XONA takes pride in offering comprehensive customer support.


Mon – Fri
10 AM to 5 PM US Eastern

Xona Microfluidics® is closed all U.S. Holidays

Follow Xona


Email Xona

951-553-6400 Phone

International Customers: Please contact Xona through our online form or by email if you would like to arrange a time to speak by phone.

Subscribe To Our Newsletter

WordPress Image Lightbox Plugin